GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
H

Huaren Pharmaceutical Co 300110.SZ · CNY

Health Care · Shenzhen · 🇨🇳 China

Compare

2.67

+0.38%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Huaren Pharmaceutical Co

Its shares trade on Shenzhen under the ticker 300110.SZ. It has been listed since 25 August 2010. In the fiscal year to 31 December 2025, it reported revenue of CN¥1.32bn and a net loss of CN¥462.9m. At that date it held total assets of CN¥2.70bn and shareholders' equity of CN¥837.9m.

Huaren Pharmaceutical Co., Ltd. engages in development, manufacture, and sale of non polyvinyl chloride and non-PVC large capacity preparations. The company is headquartered in Qingdao, Shandong. The company went IPO on 2010-08-25. The firm provides basic infusion products, including sodium chloride infusions, dextrose infusions and compound sodium chloride infusions, among others; infusion products for treatment, including metronidazole and sodium chloride infusions, ciprofloxacin lactate and sodium chloride infusions and others, as well as nutritious infusion products, among others. The firm distributes its products in domestic market, with Northeast China as its main market.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Pharmaceuticals
Listed since
25 Aug 2010
Employees
2,242

Leadership

Pay as last reported

  • Mr. Li ZhangChairman of the Board, since 2024
  • Mr. Liang HongExecutive President
  • Mr. Jian LiPresident
  • Ms. Liping HanChief Financial Officer, Vice President
  • Mr. Qian LiuChief Operating Officer
  • Ms. Xiangyuan MengVice President, Secretary of the Board
  • Mr. Xinguang FengVice President
  • Mr. Shengbin JiVice President, since 2018
  • Mr. Ming LiVice President
  • Ms. Xiaoli LiVice PresidentCN¥225,000
  • Ms. Junhong WangVice President
  • Mr. Weiwen XiaoVice President, since 2018CN¥360,000

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Huaren Pharmaceutical Co Ltd possesses several strengths that contribute to its competitive advantage. These include:

Weaknesses

  • Despite its strengths, Huaren Pharmaceutical Co Ltd also faces certain weaknesses that could hinder its growth prospects. These include:

Opportunities

  • Huaren Pharmaceutical Co Ltd can explore various opportunities to further expand its business. These include:

Threats

  • Huaren Pharmaceutical Co Ltd faces various threats in the external environment that could impact its operations. These threats include:

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.